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Abstract 
 
Background: To study the effect of routine antenatal 
daily iron supplementation on fetal weight. 
Methods: In this randomized control trial thirty two 
adult female and ten adult male Sprague- Dawley rats 
(weighing 200-250 gm) were taken. They were distributed 
randomly into two equal study groups. Ferrous sulphate 
was administered orally at 0 and 10mg/kg/day starting 
from gestation day (GD) 1, and half of the animals were 
sacrificed on GD 17 and half were sacrificed on GD 20. 
Five millilitre of maternal blood was taken through 
intracardiac route for measurement of blood haemoglobin 
and serum ferritin level. Maternal body weight was 
recorded at the start and then at the end of the experiment. 
Fetal weight was also recorded. 
Results: The results were assessed on gestational day 17 
and 20. There was no significant change in the maternal 
weight gain and number viability of fetuses of control and 
experimental groups. There was an increase in the mean 
fetal weight, maternal haemoglobin and maternal ferritin 
in iron replete rats as compared to non-iron supplemented 
(control) rats. 
Conclusion:  Antenatal daily iron supplementation is 
effective in improving fetal weight.  
Key Words: Pregnancy, ferrous sulphate 
supplementation, maternal body weight, fetal weight.. 
 
Introduction 
 
The routine use of iron prophylaxis during 
pregnancy is a subject of considerable debate, some 
advocating such practice as routine, while others 
maintain that it should only be used when clinically 
indicated. When a woman becomes pregnant her iron 
needs increase to support her pregnancy and the 
growth of her baby .Iron supplements are almost 
universally prescribed for pregnant women at doses 
ranging from 30mg/day in the United States to as high 
as 240mg/day where prevalence of anaemia is high. 
The preparation commonly used is ferrous sulphate 
200 mg three times daily . 1 
Iron (Fe) deficiency in pregnancy has serious 
consequences for both the mother and the baby. In the 
immediate postnatal period, these include increased 
risk of low birth-weight and  increased morbidity .In 
the neonatal period, there is an increased risk of 
impaired motor development and coordination. In 
children, language development and scholastic 
achievement can be affected; there are significant 
psychological and behavioural effects and decreased 
physical activity.As adults, the effects persist and can 
result in elevated blood pressure and cardiovascular 
problems. 3,4 
Iron supplementation of pregnant individuals 
with adequate iron status may aggravate oxidative 
stress , a factor which could contribute to preterm 
delivery. Iron supplements may raise the risks of 
gestational diabetes, hypertension, and metabolic 
syndrome in some women. During pregnancy, low Hb 
levels, indicative of moderate (between 70 and 90 g/L) 
or severe (less than 70 g/L) anaemia, are associated 
with increased risk of maternal and child mortality 
and infectious diseases . Significant correlations 
between maternal anaemia and low birth weight 
(LBW) and between severe iron deficiency anaemia 
and LBW have been reported On possible approach to 
reduce LBW is to reduce maternal anaemia during 
pregnancy. 5,6  
 
Material and Methods  
 
 This randomized control trial was performed 
in Army Medical College and National Institute of 
Health, from October 2010 to January 2011. 
Experimental Animals:Thirty two adult female and 
ten adult male Sprague Dawley rats weighing 150- 300 
grams were taken from the animal house of National 
Institute of Health (NIH), Islamabad. Pregnant rats 
were kept individually in clear plastic cages with heat 
treated wood chips as bedding and kept at standard 
room temperature that was maintained on 12 hour 
light/dark cycle. Animals were given routine 
laboratory diet (NIH) in the form of pellets 
supplemented with vitamins and water ad libitum. 
Dating the Pregnancy in Rats: Female rats were given 
chance to mate in the ratio of 4:1 with males overnight. 
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The presence of the vaginal plug on the following 
morning indicated pregnancy and was designated as 
gestation day 0 (GD 0). 
 
Experimental Design:The pregnant rats were 
randomly allocated into two groups of sixteen rats 
each .The first group remained on the control diet 
throughout the experiment, whilst the second group 
was treated with ferrous sulphate in a dose of 10 
mg/Kg/day. Maternal body weight was recorded at 
the start and then at the end of the experiment. 
Group A (Control Group) – (16 Rats):This Group was 
further sub-divided into two sub-groups of eight rats 
each. 
Group A-I (Control Group) – (8 Rats):They were 
given 5 cc distilled water by oral gavage tube at 9 am 
daily for 17 days starting from GD 0 to GD 16 and then 
sacrificed on the next day after the last dose. 
Group A-II (Control Group) – (8 Rats):They were 
given 5 cc distilled water by oral gavage tube at 9 am 
daily for 20 days starting from GD 0 to GD 19 and then 
sacrificed on the next day after the last dose. 
Group B (Exposed to iron supplements) – (16 
Rats):This group was further sub-divided into two 
sub-groups of eight rats each. 
Group B-I (Exposed to iron supplements) – (8 
Rats):They were given 5 cc distilled water by oral 
gavage tube containing ferrous sulphate 10 mg/kg of 
body weight/day (same as the normal human dose) at 
9 am daily for 17 days starting from GD 0 to GD 16 
and then sacrificed on the next day after the last dose. 
Group B-II (Exposed to iron supplements) – (8 
Rats):They were given 5 cc distilled water by oral 
gavage tube containing ferrous sulphate 10 mg/kg of 
body weight/day (same as the normal human dose) at 
9 am daily for 20 days starting from GD 0 to GD 19 
and then sacrificed on the next day after the last dose. 
Preparation of dosage of drug:Iron (crystalline ferrous 
sulphate FeSO4.7H20) was finely ground by mortar 
and pestle. Dose was adjusted on the basis of human 
dose which is 10 mg/Kg body weight/ day and 
weighed by means of electric balance and mixed in 
5ml of drinking water.  
Euthanasia of Animals:Before the animals were 
euthanized their final weights were taken. The animals 
were sacrificed by an overdose of ether anaesthesia. 
Cotton soaked in ether was placed into the jar. The 
animal to be sacrificed was lifted by tail and dropped 
into the jar. 
Collection of Blood Samples for Biochemical 
Assessments:When the animal became unconscious, it 
was taken out of the jar and placed on the dissecting 
board. Five millilitre of maternal blood was taken 
through intracardiac route. Two millilitre was 
collected into labelled heparinized capillary tubes for 
haemoglobin measurement. The remaining maternal 
blood was collected in labelled nonheparinized tubes 
and centrifuged at 5000rpm for 5 minutes to separate 
serum. Maternal haemoglobin was measured using 
Sysmex Kx-21 and the results were obtained within 55 
seconds. Serum ferritin was measured using Backman 
Coulter Access-2 and the results were obtained within 
45 minutes. 
 
Results 
 
All rats showed no abnormal clinical signs 
during the experimental period. The results showed 
no significant change in maternal weight gain and 
number viability of fetuses (p>0.05) of control and 
experimental groups on GD 17 and GD 20. There was 
an increase in the mean fetal weight of the iron 
supplemented rats than that of control rats at GD 17 
and GD 20. In the two groups of rats, the mean 
maternal blood hemoglobin and serum ferritin value 
was significantly greater in the experimental than the 
control rats at GD 17 and GD 20. (Table1) 
 
Table 1: Effect of antenatal iron : Comparison between 
control and experimental group 
(Number of animals in each group=16) 
 Control Gorup 
Mean + SE 
Experimental Gorup 
Mean + SE 
P- value 
 Day 17 Day 20 Day 17 Day 20  
NO* of  
fetuses 
7.0+0.42 7.13+ 0.4 7.13+0.52 7.25+0.37 >0.05 ** 
Fetal 
weight(gms) 
0.547+0.012 4.262+0.13 0.748+0.012 5.613 +0.15 < 0.001*** 
Maternal 
Hb(g/dl)  
9.35+0.131 9.47+0.144 11.463+ 0.307 11.55 + 0.234 <0.001** 
Ferritin 
 (ng/ml) 
8.17 + 0.269 11.01+ 0.262 8.80 + 0.382 11.44 + 0.266 <0.001*** 
*NO=Number; ** Not significant ; *** Highly significant  
 
Discussion 
 
Birth weight is arguably one of the strongest 
predictors of infant survival. In our study, we 
observed that antenatal daily iron supplementation led 
to a significantly increase in fetal weight. This is in 
accordance with a number of animal and human 
studies. Although it is difficult to project directly from 
rats to humans, given the differences in timing of 
development of milestones, the data supports results 
published in human studies.It is possible that iron 
supplements may be preferentially transferred to the 
placenta and fetus thus contributing to higher birth 
weight. One another mechanism to support the 
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increase in fetal weight is that iron supplementation 
may improve the appetite of the mother, thus resulting 
in increased intrauterine growth. 7 
The amount of iron that can be absorbed from 
diet alone is sufficient to cover women’s increased iron 
requirements during pregnancy except when women 
can draw enough iron from pre-pregnancy iron 
reserves. The data presented in this study showed that 
the daily use of iron supplementation during 
pregnancy raises maternal haemoglobin and serum 
ferritin level compared to the group receiving no 
supplementation. In most species, maternal blood 
volume increases and haematocrit and hemoglobin 
concentration fall during pregnancy .Iron 
supplementation with or without folic acid during 
pregnancy results in a substantial reduction in 
women’s risk of  having Hb level less than 10mg/ dl in 
late pregnancy, at delivery and six week postpartum . 
Pregnant women who received iron supplementation 
had differences in indicators of iron nutritional status 
during pregnancy in comparison with those who did 
not i.e. their Hb, iron, transferrin saturation and 
ferritin levels declined less . 8,9  
 
Conclusion 
 
Research is needed on the safe and effective 
amounts of iron and on schemes to provide in 
preventive supplementation programs on functional 
outcomes. 
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